Thomas Areschoug
Corporate Officer/Principal bij XINTELA AB
Actieve functies van Thomas Areschoug
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
XINTELA AB | Corporate Officer/Principal | 01-03-2017 | - |
Loopbaan van Thomas Areschoug
Eerdere bekende functies van Thomas Areschoug
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Invest in Skane AB
Invest in Skane AB Miscellaneous Commercial ServicesCommercial Services Invest in Skane AB provides organization consulting services. The private company is based in Skane, Sweden. | Corporate Officer/Principal | - | - |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Directeur/Bestuurslid | 01-01-2010 | - |
Oprichter | 01-01-2010 | - |
Statistieken
Internationaal
Zweden | 3 |
Denemarken | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Founder | 1 |
Sectoraal
Health Technology | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
XINTELA AB | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Invest in Skane AB
Invest in Skane AB Miscellaneous Commercial ServicesCommercial Services Invest in Skane AB provides organization consulting services. The private company is based in Skane, Sweden. | Commercial Services |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Beurs
- Insiders
- Thomas Areschoug
- Ervaring